Informations du chercheur

Nom complet

Cherqaoui Driss

Grade

PES

Spécialité

Chimie organique

Thématique de recherche

Synthèse organique et modélisation moléculaire

Laboratoire

Laboratoire de Chimie Moléculaire

Établissement

Faculté des Sciences Semlalia Marrakech

Ouvrages (0 au total)

Aucun ouvrage disponible.

Publications (36 au total)

Anti-proliferative and antidiabetic potential of vanillin-linked isoxazole hybrids targeting α-glucosidase: Synthesis, in vitro and in silico evaluation

Auteur: Mohamed Adardour, Nouhaila Ait Lahcen, Abdoussadeq Ouamnina, Marouane Ait Lahcen, Ismail Hdoufane, Mohammed M. Alanazi, Elena Zaballos-García, Imane Elateri, Driss Cherqaoui, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2026

DOI: 10.1016/j.molstruc.2025.144610

One-pot synthesis via [3+2] cycloaddition reaction, structural analysis, and computational insights of obtained oxadiazole-benzodiazepine derivatives as potential kinase inhibitors

Auteur: Samir Hmaimou, Nouhaila Ait Lahcen, Marouane Ait Lahcen, Ismail Hdoufane, Mohamed Adardour, Paola Vitale, Maria Grazia Perrone, Driss Cherqaoui, Mohamed Maatallah, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2025

DOI: 10.1016/j.molstruc.2025.143117

1,2,4-triazolo-1,5-benzodiazepine diastereoisomers: Synthesis, structural elucidation and computational insights for anti-ebola activity

Auteur: Marouane Ait Lahcen, Nouhaila Ait Lahcen, Saad Zekri, Ashwag S. Alanazi, Samir Hmaimou, Mohammed M. Alanazi, Mohamed Adardour, Ismail Hdoufane, Karim Chkirate, Joel T. Mague, Driss Cherqaoui, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2025

DOI: 10.1016/j.molstruc.2025.142736

Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer

Auteur: Mohamed Adardour, Al-Hassan M. Mustafa, Mehdi Oubahmane, Marouane Ait Lahcen, Emad M. Seif, Manal Abdel Fattah Ezzat, Elena Zaballos-García, Joel T. Mague, Ismail Hdoufane, Driss Cherqaoui, Oliver H. Krämer, Wolfgang Sippl, Hany S. Ibrahim, Abdesselam Baouid

Revue: Bioorganic Chemistry

Année: 2025

DOI: 10.1016/j.bioorg.2025.108269

Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations

Auteur: Ismail Hdoufane, Mehdi Oubahmane, Youssef Habibi, Christelle Delaite, Mohammed M. Alanazi, Driss Cherqaoui

Revue: Scientific Reports

Année: 2025

DOI: 10.1038/s41598-025-86961-5

Efficient Synthesis, Structural Characterization, DFT Analysis, and Molecular Dynamics of a Benzimidazolone Derivative as an Antidiabetic Inhibitor

Auteur: Mohamed Adardour, Nouhaila Ait Lahcen, Laura Chelazzi, Samuele Ciattini, Mohamed Maatallah, Driss Cherqaoui, Abdesselam Baouid

Revue: ChemistrySelect

Année: 2025

DOI: 10.1002/slct.202504602

Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives

Auteur: Mohamed Adardour, Soufiane Drioua, Marouane Ait Lahcen, Ismail Hdoufane, Elena Zaballos-García, Mohammed M. Alanazi, Anass Doukkali, Karim Chkirate, Driss Cherqaoui, Joel T. Mague, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2025

DOI: 10.1016/j.molstruc.2024.139683

Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus

Auteur: Wissal Liman, Mehdi Oubahmane, Nouhaila Ait Lahcen, Ismail Hdoufane, Driss Cherqaoui, Rachid Daoud, Achraf El Allali

Revue: Scientific Reports

Année: 2024

DOI: 10.1038/s41598-024-80082-1

New Schiff bases and their vanadium complexes: Synthesis, characterization, and biological assessment for antibacterial and antiviral action

Auteur: Khadija Khaldoune, Ali Hasnaoui, Meryem Rafya, Meriem Es‐sakhi, Fatiha Benkhalti, Ismail Hdoufane, Joel T. Mague, Johan Neyts, Dirk Jochmans, Driss Cherqaoui, Larbi el Firdoussi, Naima Fdil, Hassan Bihi Lazrek, Mustapha Ait Ali

Revue: Applied Organometallic Chemistry

Année: 2024

DOI: 10.1002/aoc.7534

Communications (61 au total)

Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling

Manifestation: 2nd MMCS - Facing Novel Challenges in Drug Discovery

Date: 2019-05-15

Organisation: Barcelona, Spain

Molecular modeling: Application of Artificial Neural Networks, Support Vector Machines and Decision Trees for anti HIV activity prediction of organic compounds

Manifestation: 5th International Conference on Computation for Science and Technology (ICCST 2018)

Date: 2018-09-23

Organisation: Antalya Turkey

QSAR models for assessment of the potential of azaindole analogs as HIV-1 attachment inhibitors

Manifestation: 25th Congress of the Society of Chemists and Technologists of Macedonia (SCTM)

Date: 2018-09-19

Organisation: Ohrid Macedonia

Molecular docking study to understand the binding mechanism of HIV-1 attachment inhibitors

Manifestation: The 3rd Forum of scientific research

Date: 2018-05-11

Organisation: Marrakech, Morocco

Binding energy-based approaches to enhance virtual screening in drug discovery workflows

Manifestation: International Conference on Drug Discovery: Biotechnology and Pharma at Cross Roads

Date: 2018-02-15

Organisation: Patiala-India

SAR Studies for the in-silico Prediction of HIV-1 Inhibitors

Manifestation: 3rd International Electronic Conference on Medicinal Chemistry

Date: 2017-11-01

Organisation: Online

Hydrocarbures et clusters des éléments du groupe 13, Analyse énergétiques et considérations écologiques

Manifestation: International Conference on theoretical chemistry and Modeling

Date: 2017-06-15

Organisation: Kenitra, Morocco. March 15-17, (2017).

Molecular docking study of HIV-1 attachment inhibitors

Manifestation: The XI European Workshop in Drug Design

Date: 2017-05-21

Organisation: Certosa di pontignano, Siena, Italy

Molecular modeling: Application of Support Vector Machines and Decision Trees for anti-HIV activity prediction of organic compounds

Manifestation: International Conference on Multimedia Computing and systems

Date: 2016-09-29

Organisation: Marrakech (Morocco)